Bevacizumab Adverse Event Report 2018

$19.99

This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions
Categories: ,

Description

Bevacizumab is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Bevacizumab is used to treat a certain type of brain tumor, and certain types of cancers of the kidney, lung, colon, rectum, cervix, ovary, or fallopian tube. Bevacizumab is also used to treat cancer of the membrane lining the internal organs in your abdomen. It is usually given as part of a combination of cancer medicines. Bevacizumab may also be used for purposes not listed in this medication guide.https://www.drugs.com/mtm/bevacizumab.html

Related products